{
  "id": "clinical#screening_cues_b1e71aec",
  "content": "Additional features\n• In rare instances, use of dissociative drugs, including ketamine and PCP, can\nresult in seizures.\n• Laboratory tests to quantify PCP levels are only weakly correlated with\ndisturbances in consciousness, cognition, perception, affect, behaviour or\ncoordination.\nDiagnostic requirements for disorders due to substance use | Substance intoxication\nDisorders due to substance use or addictive behaviours 479\nSubstance withdrawal\nAvailable categories by substance class\n6C40.4 Alcohol withdrawal\n6C41.4 Cannabis withdrawal\n6C42.4 Synthetic cannabinoid withdrawal\n6C43.4 Opioid withdrawal\n6C44.4 Sedative, hypnotic or anxiolytic withdrawal\n6C45.4 Cocaine withdrawal\n6C46.4 Stimulant withdrawal, including amfetamines, methamfetamine and\nmethcathinone\n6C47.4 Synthetic cathinone withdrawal\n6C48.3 Caffeine withdrawal\n6C4A.4 Nicotine withdrawal\n6C4B.4 Volatile inhalant withdrawal\n6C4C.4 MDMA or related drug withdrawal, including MDA\n6C4E.4 Other specified psychoactive substance withdrawal\n6C4F.4 Multiple specified psychoactive substances withdrawal\n6C4G.4 Withdrawal due to unknown or unspecified psychoactive substances\nEssential (required) features\n• The presentation is characterized by a clinically significant cluster of symptoms,\nbehaviours and/or physiological features that occurs upon cessation or reduction\nin the use of a substance in individuals who have developed dependence on that\nsubstance, or have used the substance for a prolonged period or in large amounts.",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues Additional features\n• In rare instances, use of dissociative drugs, including ketamine and PCP, can\nresult in seizures.\n• Laboratory tests to quantify PCP levels are only weakly correlated with\ndisturbances in consciousness, cognition, perception, affect, behaviour or\ncoordination.\nDiagnostic requirements for disorders due to substance use | Substance intoxication\nDisorders due to substance use or addictive behaviours 479\nSubstance withdrawal\nAvailable categories by substance class\n6C40.4 Alcohol withdrawal\n6C41.4 Cannabis withdrawal\n6C42.4 Synthetic cannabinoid withdrawal\n6C43.4 Opioid withdrawal\n6C44.4 Sedative, hypnotic or anxiolytic withdrawal\n6C45.4 Cocaine withdrawal\n6C46.4 Stimulant withdrawal, including amfetamines, methamfetamine and\nmethcathinone\n6C47.4 Synthetic cathinone withdrawal\n6C48.3 Caffeine withdrawal\n6C4A.4 Nicotine withdrawal\n6C4B.4 Volatile inhalant withdrawal\n6C4C.4 MDMA or related drug withdrawal, including MDA\n6C4E.4 Other specified psychoactive substance withdrawal\n6C4F.4 Multiple specified psychoactive substances withdrawal\n6C4G.4 Withdrawal due to unknown or unspecified psychoactive substances\nEssential (required) features\n• The presentation is characterized by a clinically significant cluster of symptoms,\nbehaviours and/or physiological features that occurs upon cessation or reduction\nin the use of a substance in individuals who have developed dependence on that\nsubstance, or have used the substance for a prolonged period or in large amounts. Additional features\n• in rare instances, use of dissociative drugs, including ketamine and pcp, can\nresult in seizures. • laboratory tests to quantify pcp levels are only weakly correlated with\ndisturbances in consciousn..."
}